SCHEMBL291150

SCHEMBL291150

Cc1oc2c(C)c(C)c3ccccc3c2c1C

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAOA P21397 3/20 0.36
▸ L3MBTL1 Q9Y468 3/20 0.35
▸ HPGD P15428 2/20 0.35
▸ TSHR P16473 2/20 0.35
▸ CYP3A4 P08684 1/20 0.35
▸ MAPK1 P28482 1/20 0.35
▸ CASP1 P29466 1/20 0.35
▸ RAB9A P51151 1/20 0.35
▸ CASP7 P55210 1/20 0.35
▸ ATM Q13315 1/20 0.35
▸ HIF1A Q16665 1/20 0.35
▸ HSD17B10 Q99714 1/20 0.35
▸ ALDH2 P05091 1/20 0.35
▸ GAA P10253 1/20 0.33
▸ ESR2 Q92731 3/20 0.33
▸ CYP1A2 P05177 2/20 0.32
▸ PBRM1 Q86U86 1/20 0.32
▸ KDM4E B2RXH2 2/20 0.32
▸ CYP2A6 P11509 1/20 0.30
▸ NPC1 O15118 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31084790 1.00 MAOA (0.36) MAOAL3MBTL1HPGDTSHRCYP3A4
SCHEMBL19916960 0.85 ESR2 (0.41) MAOAL3MBTL1HPGDTSHRCYP3A4
SCHEMBL27388428 0.78 MAOA (0.49) MAOAHPGDCYP3A4CASP1RAB9A
SCHEMBL8516001 0.73 CYP1A2 (0.41) MAOAL3MBTL1HPGDTSHRCYP3A4
SCHEMBL11554056 0.71 MAOA (0.50) MAOAHPGDCYP3A4MAPK1CASP1
SCHEMBL167933 0.68 CYP1A2 (0.53) L3MBTL1HPGDTSHRCYP3A4MAPK1
SCHEMBL29660297 0.68 CYP1A2 (0.53) L3MBTL1HPGDTSHRCYP3A4MAPK1
SCHEMBL357443 0.68 CYP1A2 (0.53) L3MBTL1HPGDTSHRCYP3A4MAPK1
SCHEMBL18327971 0.66 KMT2A (0.39) MAOAL3MBTL1HPGDTSHRCYP3A4
SCHEMBL28539881 0.66 CYP1A2 (0.50) L3MBTL1HPGDTSHRCYP3A4MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 93 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109640937-A Antiperspirant or deodorant compositions 弗门尼舍有限公司 2019-04-16 — — CN claimed
CN-102695695-B organic compounds 奇华顿股份有限公司 2017-07-28 — — CN claimed
CN-1874749-A Fragrance composition comprising residual accords PROCTER & GAMBLE (US) 2006-12-06 — — CN claimed
US-6241979-B1 Perfumed products containing a mixture of perfume materials having antibacterial properties QUEST INTERNATIONAL B.V. (NL) 2001-06-05 — — US claimed
EP-1061894-A1 FRAGRANCE ENHANCING COMPOSITIONS FOR COSMETIC PRODUCTS Colgate-Palmolive Company (US) 2000-12-27 — — EP claimed
WO-1999044575-A1 FRAGRANCE ENHANCING COMPOSITIONS FOR COSMETIC PRODUCTS COLGATE-PALMOLIVE COMPANY (US) 1999-09-10 — — WO claimed
EP-4676920-A1 PHOTOLABILE CYCLIC ACETALS AND KETALS FOR THE LIGHT-INDUCED DELIVERY OF ACTIVE ALDEHYDES AND KETONES Firmenich SA (CH) 2026-01-14 — — EP disclosed
US-12290591-B2 Fragrance compositions FIRMENICH SA (CH) 2025-05-06 — — US disclosed
WO-2024218086-A1 PHOTOLABILE CYCLIC ACETALS AND KETALS FOR THE LIGHT-INDUCED DELIVERY OF ACTIVE ALDEHYDES AND KETONES FIRMENICH SA (CH) 2024-10-24 — — WO disclosed
WO-2024068907-A1 LILY OF THE VALLEY ODORANT FIRMENICH SA (CH) 2024-04-04 — — WO disclosed
WO-2023209139-A1 MUSKY ODORANT FIRMENICH SA (CH) 2023-11-02 — — WO disclosed
WO-2023094502-A1 PROCESS FOR PREPARING A CYCLIC DIENE FIRMENICH SA (CH) 2023-06-01 — — WO disclosed
US-11352588-B2 Musk-like composition KAO CORPORATION (JP) 2022-06-07 — — US disclosed
US-6680289-B1 COMPRISING AN EFFECTIVE AMOUNT OF MALODOR COUNTERACTANT COMPRISING SOLUBILIZED, UNCOMPLETED CYCLODEXTRIN AND A CASTOR OIL SURFACTANT THE PROCTOR & GAMBLE COMPANY 2004-01-20 — — US disclosed
US-6436442-B1 DEODORIZING THE PROCTER & GAMBLE COMPANY 2002-08-20 — — US disclosed
US-6379658-B1 CONSISTING OF BETA-NAPHTHYL METHYL ETHER, BETA-NAPHTHYL KETONE, BENZYL ACETONE, HEXAHYDRO-4,7-METHANOINDEN-5-YL AND 6-YL PROPIONATES, GAMMA-METHYL IONONE, FURAN DERIVATIVE, 3,7-DIMETHYL-2,6-NONADIEN-1-NITRILE, CYCLIC ESTER, KETONE INTERNATIONAL FLAVORS & FRAGRANCES INC. 2002-04-30 — — US disclosed
EP-1061894-A1 FRAGRANCE ENHANCING COMPOSITIONS FOR COSMETIC PRODUCTS Colgate-Palmolive Company (US) 2000-12-27 — — EP disclosed
US-6136769-A DETERGENT COMPOSITION COMPRISING A LINEAR OR BRANCHED CHAIN ALKYL SULFATE SURFACTANT, AN ALKYL BENZENE SULFONATE SURFACTANT, AND AN ALKOXYLATED CATIONIC SURFACTANT AND A BUILDER COMPRISING MIXTURE OF ZEOLITE AND LAYERED SILICATE THE PROCTER & GAMBLE COMPANY (US) 2000-10-24 — — US disclosed
WO-1999044575-A1 FRAGRANCE ENHANCING COMPOSITIONS FOR COSMETIC PRODUCTS COLGATE-PALMOLIVE COMPANY (US) 1999-09-10 — — WO disclosed
US-5630847-A Perfumable dry cleaning and spot removal process THE PROCTER & GAMBLE COMPANY (US) 1997-05-20 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11352588-B2 Musk-like composition MSI2, MUS81, KLK7 MAOA 1055/4885L3MBTL1 2610/4885HPGD 4240/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback